These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23880145)
1. Plasma gelsolin levels and outcomes after aneurysmal subarachnoid hemorrhage. Pan JW; He LN; Xiao F; Shen J; Zhan RY Crit Care; 2013 Jul; 17(4):R149. PubMed ID: 23880145 [TBL] [Abstract][Full Text] [Related]
2. Plasma visfatin, a possible prognostic marker in aneurysmal subarachnoid hemorrhage. Wang JX; Hou Y; Ruan SP; Wang J; Hu XM Peptides; 2013 Dec; 50():8-12. PubMed ID: 24120704 [TBL] [Abstract][Full Text] [Related]
3. Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage. Zhu XD; Chen JS; Zhou F; Liu QC; Chen G; Zhang JM Crit Care; 2011; 15(6):R288. PubMed ID: 22126444 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of plasma soluble CD40 ligand levels following aneurysmal subarachnoid hemorrhage. Chen XD; Sun J; Lu C; Ba HJ; Chen MH; Lin JH; Cai JY Thromb Res; 2015 Jul; 136(1):24-9. PubMed ID: 25944664 [TBL] [Abstract][Full Text] [Related]
5. Circulating levels of neuropeptide proenkephalin A predict outcome in patients with aneurysmal subarachnoid hemorrhage. Chen XL; Yu BJ; Chen MH Peptides; 2014 Jun; 56():111-5. PubMed ID: 24727154 [TBL] [Abstract][Full Text] [Related]
6. Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Weiss N; Sanchez-Peña P; Roche S; Beaudeux JL; Colonne C; Coriat P; Puybasset L Anesthesiology; 2006 Apr; 104(4):658-66. PubMed ID: 16571959 [TBL] [Abstract][Full Text] [Related]
7. Relationship between plasma high mobility group box-1 protein levels and clinical outcomes of aneurysmal subarachnoid hemorrhage. Zhu XD; Chen JS; Zhou F; Liu QC; Chen G; Zhang JM J Neuroinflammation; 2012 Aug; 9():194. PubMed ID: 22883976 [TBL] [Abstract][Full Text] [Related]
8. Identification of plasma adrenomedullin as a possible prognostic biomarker for aneurysmal subarachnoid hemorrhage. Cai JY; Chen XD; Ba HJ; Lin JH; Lu C; Chen MH; Sun J Peptides; 2014 Sep; 59():9-13. PubMed ID: 25009125 [TBL] [Abstract][Full Text] [Related]
9. Leptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage. Fan XF; Chen ZH; Huang Q; Dai WM; Jie YQ; Yu GF; Wu A; Yan XJ; Li YP Peptides; 2013 Oct; 48():70-4. PubMed ID: 23954475 [TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of cleaved RAGE plasma levels as a biomarker of disease severity and functional outcome in aneurysmal subarachnoid hemorrhage. Yang DB; Dong XQ; Du Q; Yu WH; Zheng YK; Hu W; Wang KY; Chen FH; Xu YS; Wang Y; Chen G Clin Chim Acta; 2018 Nov; 486():335-340. PubMed ID: 30144440 [TBL] [Abstract][Full Text] [Related]
11. Thioredoxin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage. Dai JX; Cai JY; Lin Q; Chen XD; Lu C; Sun J; Ba HJ J Neurol Sci; 2016 Apr; 363():84-9. PubMed ID: 27000227 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of plasma galectin-3 levels after aneurysmal subarachnoid hemorrhage. Liu H; Liu Y; Zhao J; Liu H; He S Brain Behav; 2016 Oct; 6(10):e00543. PubMed ID: 27781149 [TBL] [Abstract][Full Text] [Related]
13. Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage: Data From the Simvastatin in Aneurysmal Subarachnoid Hemorrhage (STASH) Trial. Turner CL; Budohoski K; Smith C; Hutchinson PJ; Kirkpatrick PJ; Murray GD; Neurosurgery; 2015 Nov; 77(5):786-92; discussion 792-3. PubMed ID: 26280117 [TBL] [Abstract][Full Text] [Related]
14. Increased serum interleukin-33 concentrations predict worse prognosis of aneurysmal subarachnoid hemorrhage. Gong J; Zhu Y; Yu J; Jin J; Chen M; Liu W; Zhan R Clin Chim Acta; 2018 Nov; 486():214-218. PubMed ID: 30102896 [TBL] [Abstract][Full Text] [Related]
15. The change of plasma pituitary adenylate cyclase-activating polypeptide levels after aneurysmal subarachnoid hemorrhage. Jiang L; Wang WH; Dong XQ; Yu WH; Du Q; Yang DB; Wang H; Shen YF Acta Neurol Scand; 2016 Aug; 134(2):131-9. PubMed ID: 26471292 [TBL] [Abstract][Full Text] [Related]
16. Plasma-type gelsolin in subarachnoid hemorrhage: novel biomarker today, therapeutic target tomorrow? Chou SH; Lo EH; Ning M Crit Care; 2014 Jan; 18(1):101. PubMed ID: 24393331 [TBL] [Abstract][Full Text] [Related]
17. Caspase-3 in serum predicts outcome after aneurysmal subarachnoid hemorrhage. Wang J; Wang JF; Hu XM Clin Chim Acta; 2016 Sep; 460():196-202. PubMed ID: 27380999 [TBL] [Abstract][Full Text] [Related]
18. Comparison of plasma copeptin and multiple biomarkers for assessing prognosis of patients with aneurysmal subarachnoid hemorrhage. Zheng YK; Dong XQ; Du Q; Wang H; Yang DB; Zhu Q; Che ZH; Shen YF; Jiang L; Hu W; Wang KY; Yu WH Clin Chim Acta; 2017 Dec; 475():64-69. PubMed ID: 29037840 [TBL] [Abstract][Full Text] [Related]
19. Plasma 8-iso-Prostaglandin F2α, a possible prognostic marker in aneurysmal subarachnoid hemorrhage. Pan DS; Yan M; Hassan M; Fang ZB; Chen MT Clin Chim Acta; 2017 Jun; 469():166-170. PubMed ID: 28408198 [TBL] [Abstract][Full Text] [Related]
20. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Sanchez-Peña P; Pereira AR; Sourour NA; Biondi A; Lejean L; Colonne C; Boch AL; Al Hawari M; Abdennour L; Puybasset L Crit Care Med; 2008 Aug; 36(8):2267-73. PubMed ID: 18596638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]